Puma Biotechnology
PBYI
119 hedge funds and large institutions have $893M invested in Puma Biotechnology in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 32 closing their positions.
53% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 32
44% more call options, than puts
Call options by funds: $13.8M | Put options by funds: $9.56M
5.64% less ownership
Funds ownership: 99.26% → 93.61% (-5.6%)
11% less funds holding
Funds holding: 133 → 119 (-14)
41% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 32
65% less capital invested
Capital invested by funds: $2.52B → $893M (-$1.63B)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$61.4M |
| 2 |
O
OrbiMed
New York
|
+$23.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$13.6M |
| 4 |
VAM
Visium Asset Management
New York
|
+$9.76M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$52M |
| 2 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$40.2M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$23.1M |
| 4 |
CCI
Columbus Circle Investors
|
-$21.4M |
| 5 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
-$21.3M |
PBYI Hedge Fund Activity: Q1 2016 in Review
119 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Puma Biotechnology (PBYI) for Q1 2016, worth a combined $893M — down 65% from $2.52B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of PBYI and 19 opened new positions — a net loss of 13 holders — while 32 trimmed existing stakes and 49 added.
The largest buyer was Janus Henderson Investors US, adding an estimated $61.4M. The largest seller was Capital Research Global Investors, cutting an estimated $52M.
- 119 institutional investors held Puma Biotechnology (PBYI) as of Q1 2016, down from 133 in Q4 2015.
- Funds reported $893M of Puma Biotechnology stock for Q1 2016, down 65% quarter-over-quarter.
- 19 funds opened new Puma Biotechnology positions in Q1 2016 and 32 closed out, a net change of -13 holders.
- The largest Puma Biotechnology buyer in Q1 2016 was Janus Henderson Investors US, an estimated $61.4M added.
- The largest Puma Biotechnology seller in Q1 2016 was Capital Research Global Investors, an estimated $52M sold.
Based on aggregated 13F filings for Q1 2016.